Evidence for the existence of adaptive thermogenesis during weight loss

British Journal of Nutrition

Volumn 85, Issue 6, 2001, Pages 715-723

  Doucet, Eric ^a   St Pierre, Sylvie ^a   Alméras, Natalie ^a   Després, Jean Pierre ^a   Bouchard, Claude ^b   Tremblay, Angelo ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Adaptive thermogenesis; Resting energy expenditure; Weight loss

Indexed keywords

FENFLURAMINE; PLACEBO;

ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENERGY EXPENDITURE; FEMALE; HUMAN; MALE; MATHEMATICAL COMPUTING; MULTIPLE REGRESSION; OBESITY; PREDICTION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; THERMOGENESIS; WEIGHT REDUCTION;

EID: 0034958813     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/bjn2001348     Document Type: Article

References (40)

1. Autonomic nervous system activity in weight gain and weight loss
2. Obesity as an adaptation to a high-fat diet: Evidence from a cross-sectional study
3. Gender difference in the effect of body composition on energy metabolism
4. Changes in energy expenditure and substrate oxidation resulting from weight loss in obese men and women: Is there an important contribution of leptin?
5. Poststarvation hyperphagia and body fat overshooting in humans: A role for feedback signals from lean and fat tissues
6. Lower sedentary metabolic rate in women compared with men
7. Serum leptin and weight reduction in female obesity
8. The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs
9. Effects of dexfenfluramine treatment on body weight and postprandial thermogenesis in obese subjects. A double-blind placebo-controlled study
10. Diminished energy requirements in reduced-obese patients
11. Changes in energy expenditure resulting from altered body weight
12. Do circulating leptin concentrations reflect body adiposity or energy flux?
13. Volume of the lung determined by helium dilution
14. Predictors of weight maintenance
15. Physiological responses to slimming
16. Lack of major cardiac valvular abnormalities in asymptomatic obese men and women following a 3-month fenfluramine or dexfenfluramine treatment
17. Determinants of 24-hour energy expenditure in man
18. Reduced rate of energy expenditure as a risk factor for body-weight gain
19. Effect of dexfenfluramine on energy expenditure in obese patients on a very-low-calorie diet
20. Effects of changes in body weight on carbohydrate metabolism, catecholamine excretion, and thyroid function
21. Effects of energy restriction and exercise on the sympathetic nervous system
22. The acute effect of dexfenfluramine on resting metabolic rate and postprandial thermogenesis in obese subjects: A double-blind placebo-controlled study
23. Role of fat oxidation in the long-term stabilization of body weight in obese women
24. The gross composition of the body
25. Relationship between muscle sympathetic nervous activity and plasma leptin concentration
26. Chronic fenfluramine treatment: Effects on body weight, food intake and energy expenditure
27. Overfeeding and energy expenditure in humans
28. Effects of dexfenfluramine on resting metabolic rate and thermogenesis in premenopausal obese women during therapeutic weight reduction
29. Reduction of sleeping metabolic rate after vertical banded gastroplasty
30. Short- and long-term changes in serum leptin dieting obese women: Effects of caloric restriction and weight loss
31. Effects of weight cycling on the resting energy expenditure and body composition of obese women
32. The effect of fenfluramine on weight loss during restricted dietary regimes
33. New methods for calculating metabolic rate with special reference to protein metabolism
34. An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group
35. Body mass, body composition and sleeping metabolic rate before, during and after endurance training
36. Energy metabolism after 2 y of energy restriction: The biosphere 2 experiment
37. Effect of prolonged moderate and severe energy restriction and refeeding on plasma leptin concentrations in obese women